Yaoxue Xuebao

Submission On

( Vol 60 , Issue 03 ) |

20 Aug 2025
Day
Hour
Min
Sec
Publish On

( Vol 60 , Issue 03 ) |

31 Aug 2025
Scopus Indexed (2025) scopus
ABCD Indexed (2025) scopus
scopus

Yaoxue Xuebao

Yaoxue Xuebao (ISSN:0513-4870) is a monthly peer-reviewed scopus-indexed journal from 1960, from 1962 to 1966, from 1979 to Present. The publisher of this journal is Chinese Pharmaceutical Association. Yaoxue Xuebao committed to gathering and disseminating excellent research achievements. The journal welcomes all kind of research/review/abstract papers regarding Pharmacology, Toxicology and Pharmaceutics, General Pharmacology and Toxicology and Pharmaceutics Biochemistry, Genetics and Molecular Biology and Molecular Medicine and so on.

Aim And Scope

Yaoxue Xuebao

Pharmacology

Toxicology and Pharmaceutics

General Pharmacology

Toxicology and Pharmaceutics Biochemistry

Genetics and Molecular Biology

Molecular Medicine

Latest Journal

Yaoxue Xuebao

  • YX-14-03-2025-2160
  • | Yaoxue Xuebao (ISSN:0513-4870)

Correlation between Fatty Liver Index and Obesity on the Incidence of Prediabetes, Type-II Diabetes, and Non-alcoholic Fatty Liver Disease

Our goal was to investigate the relationship between obesity and the fatty liver index and the prevalence of prediabetes, Type II diabetes, and non-alcoholic fatty liver disease. Participants in this study had their ALT and GGT levels evaluated, and questionnaires, blood pressure readings, and venous blood samples were used to determine their body composition. The participants were subsequently separated into groups according to their FLI status and BMI. The results were almost the same as those of primary research. The effects of being overweight or obese were evaluated independently in comp

read more..
  • YX-25-02-2025-2159
  • | Yaoxue Xuebao (ISSN:0513-4870)

Molecular mechanism underlying the effects of licochalcone A on abnormal gluconeogenesis and endoplasmic reticulum stress induced by type 2 diabetes mellitus

Endoplasmic reticulum stress (ERS) is activated in all cells by stressors such as hyperglycemia. However, it remains unclear which specific serum biomarkers of ERS are consistently altered in type 2 diabetes (T2D). We aimed to identify serum ERS biomarkers that are consistently altered in T2D and its complications, and their correlation with metabolic and anthropometric variables. We performed a systematic review and meta-analysis following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) and Meta-Analyses and Systematic Reviews of Observational Studies (MOOSE). T

read more..
  • YX-25-02-2025-2158
  • | Yaoxue Xuebao (ISSN:0513-4870)

Establishment of a method for determining the key parameters of hydrolysis kinetics of acid α-glucosidase for injection by ion chromatography

In recent years, food-derived hypoglycemic peptides have received a lot of attention in the study of active peptides, but their anti-diabetic mechanism of action is not yet clear. In this study, camellia seed cake protein (CSCP) was used to prepare active peptides with α-glucosidase inhibition. The optimization of the preparation of camellia seed cake protein hydrolyzed peptides (CSCPH) was conducted via response surface methodology (RSM) using a protamex with α-glucosidase inhibition as an indicator. The optimal hydrolysis conditions were pH 7.11, 4300 U/g enzyme concentration,

read more..
  • YX-25-02-2025-2157
  • | Yaoxue Xuebao (ISSN:0513-4870)

The effect of reversing drug resistance and exact mechanism of novel platinum(IV) hybrids based on GSTs inhibitors

Platinum (Pt) drugs have developed rapidly in clinical applications because of their broad and highly effective antitumor effects. In recent years, with the rapid development of immunotherapy, Pt-based antitumor agents have gained new challenges and opportunities. Since the discovery of their pharmacological effects in immunotherapy and tumor microenvironment regulation, research into Pt drugs has progressed to multi-ligand and multi-functional Pt precursors and their own shortcomings have been further highlighted. With the development of antitumor immunotherapy and the rise of combination

read more..
  • YX-25-02-2025-2156
  • | Yaoxue Xuebao (ISSN:0513-4870)

Directed evolution to enhance the catalytic activity of human arginase 1

Arginase is a widely known enzyme of the urea cycle that catalyzes the hydrolysis of L-arginine to L-ornithine and urea. The action of arginase goes beyond the boundaries of hepatic ureogenic function, being widespread through most tissues. Two arginase isoforms coexist, the type I (Arg1) predominantly expressed in the liver and the type II (Arg2) expressed throughout extrahepatic tissues. By producing L-ornithine while competing with nitric oxide synthase (NOS) for the same substrate (L-arginine), arginase can influence the endogenous levels of polyamines, proline, and NO•. Several pa

read more..

The publisher of this journal is Chinese Pharmaceutical Association. Yaoxue Xuebao committed to gathering and disseminating excellent research achievements.

Information
Guidelines
Contact Us
  • journalpublication435@gmail.com
  • admin@yaoxuexuebao-05134870.com
  • support@yaoxuexuebao-05134870.com
All rights reserved | © 2024 Yaoxue Xuebao (ISSN:0513-4870).